Dynamic Technology Lab’s Denali Therapeutics DNLI Stock Holding History

Dynamic Technology Lab’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27,429	Closed	-$589K	–	1132
2023 Q4	$589K	Buy	27,429 +4,340	+19%	+$86K	0.06%	527
2023 Q3	$476K	Buy	+23,089	New	+$586K	0.05%	506
2023 Q2	–	Sell	-11,423	Closed	-$263K	–	1092
2023 Q1	$263K	Buy	+11,423	New	+$314K	0.02%	838
2022 Q4	–	Sell	-7,140	Closed	-$219K	–	1190
2022 Q3	$219K	Buy	+7,140	New	+$232K	0.02%	928
2022 Q1	–	Sell	-12,160	Closed	-$542K	–	1193
2021 Q4	$542K	Buy	+12,160	New	+$576K	0.06%	538
2021 Q2	–	Sell	-6,570	Closed	-$375K	–	1211
2021 Q1	$375K	Buy	+6,570	New	+$440K	0.04%	705
2019 Q2	–	Sell	-17,104	Closed	-$397K	–	1034
2019 Q1	$397K	Buy	+17,104	New	+$358K	0.07%	527
2018 Q3	–	Sell	-13,585	Closed	-$207K	–	1089
2018 Q2	$207K	Buy	+13,585	New	+$256K	0.03%	836

Other funds holding DNLI

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Dynamic Technology Lab's DNLI Position: Q1 2024 in Review

Dynamic Technology Lab sold out of Denali Therapeutics (DNLI) in Q1 2024, closing a stake of 27,429 shares — an estimated $589K sold.

Dynamic Technology Lab first reported a position in DNLI in Q2 2018 and held it in 8 quarters. The position peaked at $589K in Q4 2023. 210 funds tracked by Wall St. Rank hold DNLI as of Q1 2024.

Dynamic Technology Lab reported no remaining Denali Therapeutics position as of Q1 2024 after selling out during the quarter.
Dynamic Technology Lab sold 27,429 Denali Therapeutics shares in Q1 2024, an estimated $589K.
Dynamic Technology Lab first reported a position in Denali Therapeutics in Q2 2018 and held it in 8 quarters.
Dynamic Technology Lab's Denali Therapeutics position peaked at $589K in Q4 2023.
210 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.